Original disclosure @ ADB website
Updated in EWS Mar 14, 2023
Disclosed by Bank Feb 15, 2022
Can you contribute information about this project?
Contact the EWS Team
According to the bank's website, the "project will support the procurement of an estimated 14.5 million doses of safe and effective COVID-19 vaccines via the APVAX rapid response component (RRC) and the AIIB loan. It will contribute to the government's goal of strengthening population immunity by providing booster doses and primary vaccination to children below 5. The project will also help to develop and disseminate social and gender-inclusive guidelines to ensure equitable coverage of COVID-19 vaccination".
Elfving, Rikard N. (ADB Officer)
Southeast Asia Department
Human and Social Development Division, SERD
Executing Agency: Ministry of Health
ACCESS TO INFORMATION
You can submit an information request for project information at: https://www.adb.org/forms/request-information-form
ADB has a two-stage appeals process for requesters who believe that ADB has denied their request for information in violation of its Access to Information Policy. You can learn more about filing an appeal at: https://www.adb.org/site/disclosure/appeals
ACCOUNTABILITY MECHANISM OF ADB
The Accountability Mechanism is an independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an Asian Development Bank-financed project. If you submit a complaint to the Accountability Mechanism, they may investigate to assess whether the Asian Development Bank is following its own policies and procedures for preventing harm to people or the environment. You can learn more about the Accountability Mechanism and how to file a complaint at: http://www.adb.org/site/accountability-mechanism/main.